Aura Biosciences Obtains $4,500,000 Series B Funding

  • Feed Type
  • Date
    9/8/2011
  • Company Name
    Aura Biosciences
  • Mailing Address
    One Broadway 14th Floor Cambridge, MA 02142
  • Company Description
    Aura Biosciences is a next generation biotech company – combining the expertise of leading academic institutions through research and licensing agreements, with the flexibility and efficiency of a dedicated team of in-house scientists, deal-makers, and world class advisors.
  • Website
    http://www.aurabiosciences.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $4,500,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The funds will be used to build Aura’s infrastructure and team, and to move toward the company’s first investigational new drug (IND) application before the end of 2012.
  • M&A Terms
  • Venture Investor
    Undisclosed